Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02617342 · ClinicalTrials.gov registry record · NA

Robot-Mediated Intervention for Children With Autism Spectrum Disorders

A NA study of Autism Spectrum Disorder, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT02617342 is a NA study of Autism Spectrum Disorder that has completed, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 40 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02617342, a NA study of Autism Spectrum Disorder, has completed, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study is being done to examine the impact of an interactive, social robotics program in helping children with autism spectrum disorders (ASD) understand emotions and how to better recognize emotions while interacting with others. Eligible families will be randomized to either the robot intervention (n=20) or a no intervention (TAU; n=20) condition for 8-14 weeks. Assessments will occur at pre- and post-intervention as well as weekly for both conditions.

Conditions Studied

Interventions

  • BEHAVIORAL Robot-mediated Intervention

Study Locations (1)

Maryland

  • Kennedy Krieger Institute - Baltimore

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2015-11
Est. Completion 2018-02-01
Phase NA

What the Registry Record Tells You About NCT02617342

The ClinicalTrials.gov registry entry for NCT02617342 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (70% lower). The listed sponsor is Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Robot-mediated Intervention is the first listed.

NCT02617342 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT02617342 about?

NCT02617342 is a clinical study titled "Robot-Mediated Intervention for Children With Autism Spectrum Disorders". This study is being done to examine the impact of an interactive, social robotics program in helping children with autism spectrum disorders (ASD) understand emotions and how to better recognize emotions while interacting with others. Eligible families will be randomized to either the robot interven...

What is the current status of trial NCT02617342?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-11. Estimated completion is 2018-02-01.

What conditions does trial NCT02617342 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT02617342?

The interventions under investigation include: Robot-mediated Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02617342?

This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02617342 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.